Anders CK - Search Results

1

The management of early-stage and metastatic triple-negative breast cancer: a review.

Anders CK, Zagar TM, Carey LA. Anders CK, et al. Hematol Oncol Clin North Am. 2013 Aug;27(4):737-49, viii. doi: 10.1016/j.hoc.2013.05.003. Epub 2013 Jun 18. Hematol Oncol Clin North Am. 2013. PMID: 23915742 Free PMC article. Review.

2

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.

Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM. Morse MA, et al. J Transl Med. 2007 Sep 6;5:42. doi: 10.1186/1479-5876-5-42. J Transl Med. 2007. PMID: 17822557 Free PMC article. Clinical Trial.

3

Age-specific differences in oncogenic pathway deregulation seen in human breast tumors.

Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, Foekens JA, Zhang Y, Wang Y, Marcom K, Marks JR, Mukherjee S, Nevins JR, Blackwell KL, Potti A. Anders CK, et al. PLoS One. 2008 Jan 2;3(1):e1373. doi: 10.1371/journal.pone.0001373. PLoS One. 2008. PMID: 18167534 Free PMC article.

4

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.

Anders C, Marcom PK, Peterson B, Gu L, Unruhe S, Welch R, Lyons P, Behera M, Copland S, Kimmick G, Shaw H, Snyder S, Antenos M, Woodruff T, Blackwell K. Anders C, et al. Cancer Invest. 2008 Apr-May;26(3):286-95. doi: 10.1080/07357900701829777. Cancer Invest. 2008. PMID: 18317970 Free PMC article.

5

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.

Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A. Salter KH, et al. Among authors: anders ck. PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908. PLoS One. 2008. PMID: 18382681 Free PMC article. Retracted.

6

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. Acharya CR, et al. Among authors: anders ck. JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. JAMA. 2008. PMID: 18387932 Retracted.

7

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Anders CK, et al. J Clin Oncol. 2008 Jul 10;26(20):3324-30. doi: 10.1200/JCO.2007.14.2471. J Clin Oncol. 2008. PMID: 18612148

8

Understanding and treating triple-negative breast cancer.

Anders C, Carey LA. Anders C, et al. Oncology (Williston Park). 2008 Oct;22(11):1233-9; discussion 1239-40, 1243. Oncology (Williston Park). 2008. PMID: 18980022 Free PMC article. Review.

9

Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer.

Anders CK, Peppercorn J. Anders CK, et al. Cancer Invest. 2009 Jan;27(1):13-6. doi: 10.1080/07357900802484944. Cancer Invest. 2009. PMID: 19160108 Review. No abstract available.

10

Breast cancer before age 40 years.

Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Anders CK, et al. Semin Oncol. 2009 Jun;36(3):237-49. doi: 10.1053/j.seminoncol.2009.03.001. Semin Oncol. 2009. PMID: 19460581 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results